Bristol-Myers Squibb Co  

(Public, OTCMKTS:BMYMP)   Watch this stock  
Find more results for NYSE:BMY-
0.00 (0.00%)
Oct 5 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 980.15 - 1,182.59
Open     -
Vol / Avg. 0.00/1.00
Mkt cap 103.34B
P/E 1,008.81
Div/yield 0.37/0.14
EPS 1.07
Shares 4,178.00
Beta -16.65
Inst. own 29341796%
Oct 27, 2015
Q3 2015 Bristol-Myers Squibb Co Earnings Call - 11:30AM EDT - Add to calendar
Oct 27, 2015
Q3 2015 Bristol-Myers Squibb Co Earnings Release - 9:30AM EDT - Add to calendar
Oct 1, 2015
Bristol-Myers Squibb Co at Leerink Partners Immuno-Oncology Roundtable
Sep 17, 2015
Bristol-Myers Squibb Co at Morgan Stanley Healthcare Conference
Sep 8, 2015
Bristol-Myers Squibb Co to Discuss World Conference on Lung Cancer (WCLC) Highlights
Jul 23, 2015
Q2 2015 Bristol-Myers Squibb Co Earnings Call
Jul 23, 2015
Q2 2015 Bristol-Myers Squibb Co Earnings Release

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -2.64% 12.78%
Operating margin 1.08% 11.41%
EBITD margin - 28.60%
Return on average assets -1.35% 5.61%
Return on average equity -3.40% 13.36%
Employees 25,000 -
CDP Score - 98 B


NEW YORK, NY 10154
United States - Map
+1-212-5464000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

About Company - Wikipedia


Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products across the world. The Company's products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. The Company manufactures its products in the United States, Puerto Rico and in six foreign countries. The Company promotes the use of its products directly to healthcare professionals and providers, such as doctors, nurse practitioners, physician assistants, pharmacists, technologists, hospitals, Pharmacy Benefit Managers (PBMs) and Managed Care Organizations (MCOs). It also provides information about the use of its products to consumers in the United States through direct-to-consumer print, radio, television, and digital advertising and promotion. In addition, the Company holds rights to F001287, which is a preclinical, small-molecule IDO1-inhibitor.

Officers and directors

Giovanni Caforio M.D. Chief Executive Officer, Director
Age: 50
Charles A. Bancroft Chief Financial Officer, Executive Vice President
Age: 55
Louis S Schmukler President - Global Manufacturing and Supply
Age: 59
Francis M. Cuss Executive Vice President, Chief Scientific Officer
Age: 60
Sandra Leung Executive Vice President, General Counsel and Corporate Secretary
Age: 54
Trading Activity - Yahoo Finance
Paul von Autenried Senior Vice President - Enterprise Services, Chief Information Officer
Age: 53
Anne Nielsen Senior Vice President, Chief Compliance and Ethics Officer
Age: 54
Joseph C. Caldarella Senior Vice President, Corporate Controller
Age: 59
Trading Activity - Yahoo Finance
Ann Powell Judge Senior Vice President - Global Human Resources
Age: 49
John E. Elicker Senior Vice President - Public Affairs
Age: 55